SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines

• Published in: Molecular and cellular biochemistry 2023-02, Vol.478 (2), p.305-315
• Main Authors: Chao, Tsu-Yang, Kordaß, Theresa, Osen, Wolfram, Eichmüller, Stefan B.
• Format: Article
• Language: English
• Subjects: 3' Untranslated Regions; Analysis; Apoptosis; Binding; Biochemistry; Biomedical and Life Sciences; Breast cancer; Breast Neoplasms - pathology; Cardiology; Cell Line, Tumor; Cell Movement; Cell Proliferation - genetics; Deregulation; Development and progression; Female; Gene expression; Gene Expression Regulation, Neoplastic; Genes; Genetic translation; Humans; Life Sciences; MCF-7 Cells; Medical Biochemistry; MicroRNA; MicroRNAs - genetics; MicroRNAs - metabolism; miRNA; Oncology; Site-directed mutagenesis; Sox9 protein; SOX9 Transcription Factor - genetics; SOX9 Transcription Factor - metabolism; Suppressors; Transfection; Tumor cell lines; Tumors
• ISSN: 0300-8177; 1573-4919
• DOI: 10.1007/s11010-022-04507-z

The transcription factor SOX9 represents an important mediator of breast cancer progression. miRNAs are small non-coding RNAs inhibiting translation of target genes upon interaction with the 3′-UTR region of respective mRNA molecules. Deregulated miRNA expression is involved in hallmarks of cancer like sustained proliferation and inhibition of apoptosis. Here, we investigated the miRNA-mediated regulation of SOX9 expression in two breast cancer cell lines, thereby providing further insights into cellular mechanisms driving breast cancer progression. The modulating effects of miR-134-3p, miR-224-3p, and miR-6859-3p on SOX9 expression were analyzed by qPCR and Western blot in human MDA-MB-231 breast cancer cells. Direct binding of the above-mentioned miRNAs to the SOX9 3′-UTR was assessed by luciferase reporter assays and site-directed mutagenesis. Expression levels of the investigated miRNAs in tumor samples versus healthy tissues were analyzed in silico using publicly available databases. Transfection of miR-134-3p, miR-224-3p, or miR-6859-3p reduced SOX9 expression on mRNA and protein level. Reporter assays proved direct binding of miR-134-3p and miR-224-3p to the SOX9 3′-UTR in MDA-MB-231 and MCF-7 cells. Expression analysis performed in silico revealed reduced expression of both miRNAs in breast cancer tissues. We describe three novel miRNAs targeting SOX9 in human breast cancer cell lines. Among them miR-134-2p and miR-224-3p might act as tumor suppressors, whose down-regulation induces elevated SOX9 levels thereby promoting breast cancer progression.